Trial Site Detail

 

Drug:
Entrectinib
Trial:
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK1/2/3, ROS1, or ALK Gene Rearrangements (Fusions) (STARTRK-2)
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Active, not recruiting

 

Masonic Cancer Center at University of Minnesota

     
Minneapolis , MN 55455
USA

 

Principal Investigator:
Contact:
Contact: Manish Patel, MD
Activation Status of this Site:
Closed
Notes about this Site:
Masonic Cancer Center at University of Minnesota Website:
http://www.cancer.umn.edu/research/clinicaltrials/index.php

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.